These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23418396)

  • 81. Cytoskeleton Protein Filamin A Is Required for Efficient Somatostatin Receptor Type 2 Internalization and Recycling through Rab5 and Rab4 Sorting Endosomes in Tumor Somatotroph Cells.
    Treppiedi D; Mangili F; Giardino E; Catalano R; Locatelli M; Lania AG; Spada A; Arosio M; Calebiro D; Mantovani G; Peverelli E
    Neuroendocrinology; 2020; 110(7-8):642-652. PubMed ID: 31574507
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Neuropeptide Y Y2 receptor and somatostatin sst2 receptor coupling to mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells.
    Connor M; Yeo A; Henderson G
    Br J Pharmacol; 1997 Feb; 120(3):455-63. PubMed ID: 9031749
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Somatostatin receptor sst2 gene transfer in human prolactinomas in vitro: impact on sensitivity to dopamine, somatostatin and dopastatin, in the control of prolactin secretion.
    Cuny T; Mohamed A; Graillon T; Roche C; Defilles C; Germanetti AL; Couderc B; Figarella-Branger D; Enjalbert A; Barlier A; Saveanu A
    Mol Cell Endocrinol; 2012 May; 355(1):106-13. PubMed ID: 22348806
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Molecular biology of somatostatin receptor subtypes.
    Patel YC; Greenwood M; Panetta R; Hukovic N; Grigorakis S; Robertson LA; Srikant CB
    Metabolism; 1996 Aug; 45(8 Suppl 1):31-8. PubMed ID: 8769376
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Effect of somatostatin on nitric oxide production in human retinal pigment epithelium cell cultures.
    Vasilaki A; Papadaki T; Notas G; Kolios G; Mastrodimou N; Hoyer D; Tsilimbaris M; Kouroumalis E; Pallikaris I; Thermos K
    Invest Ophthalmol Vis Sci; 2004 May; 45(5):1499-506. PubMed ID: 15111608
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Genetic abnormalities of somatostatin receptors in pituitary tumors.
    Lania A; Mantovani G; Spada A
    Mol Cell Endocrinol; 2008 May; 286(1-2):180-6. PubMed ID: 17913341
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Somatostatin receptor subtypes sst1 and sst2 elicit opposite effects on the response to glutamate of mouse hypothalamic neurones: an electrophysiological and single cell RT-PCR study.
    Lanneau C; Viollet C; Faivre-Bauman A; Loudes C; Kordon C; Epelbaum J; Gardette R
    Eur J Neurosci; 1998 Jan; 10(1):204-12. PubMed ID: 9753128
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Visualisation of non-glycosylated somatostatin receptor two (ngsst2) immunoreactivity in the rat central nervous system.
    Hervieu G; Emson PC
    Brain Res Mol Brain Res; 1998 Jul; 58(1-2):138-55. PubMed ID: 9685616
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Protein kinase C activation stimulates the phosphorylation and internalization of the sst2A somatostatin receptor.
    Hipkin RW; Wang Y; Schonbrunn A
    J Biol Chem; 2000 Feb; 275(8):5591-9. PubMed ID: 10681540
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Characterisation of human recombinant somatostatin receptors. 3. Modulation of adenylate cyclase activity.
    Siehler S; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):510-21. PubMed ID: 10598790
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A potential inhibitory role for the new truncated variant of somatostatin receptor 5, sst5TMD4, in pituitary adenomas poorly responsive to somatostatin analogs.
    Durán-Prado M; Saveanu A; Luque RM; Gahete MD; Gracia-Navarro F; Jaquet P; Dufour H; Malagón MM; Culler MD; Barlier A; Castaño JP
    J Clin Endocrinol Metab; 2010 May; 95(5):2497-502. PubMed ID: 20233783
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Functional characterisation of the putative somatostatin sst2 receptor antagonist CYN 154806.
    Nunn C; Schoeffter P; Langenegger D; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Jan; 367(1):1-9. PubMed ID: 12616335
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies.
    Vezzosi D; Bennet A; Rochaix P; Courbon F; Selves J; Pradere B; Buscail L; Susini C; Caron P
    Eur J Endocrinol; 2005 May; 152(5):757-67. PubMed ID: 15879362
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Phosphorylation of four amino acid residues in the carboxyl terminus of the rat somatostatin receptor subtype 3 is crucial for its desensitization and internalization.
    Roth A; Kreienkamp HJ; Meyerhof W; Richter D
    J Biol Chem; 1997 Sep; 272(38):23769-74. PubMed ID: 9295322
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Relevance of coexpression of somatostatin and dopamine D2 receptors in pituitary adenomas.
    Saveanu A; Jaquet P; Brue T; Barlier A
    Mol Cell Endocrinol; 2008 May; 286(1-2):206-13. PubMed ID: 18241980
    [TBL] [Abstract][Full Text] [Related]  

  • 96. BIM-23A760 influences key functional endpoints in pituitary adenomas and normal pituitaries: molecular mechanisms underlying the differential response in adenomas.
    Ibáñez-Costa A; López-Sánchez LM; Gahete MD; Rivero-Cortés E; Vázquez-Borrego MC; Gálvez MA; de la Riva A; Venegas-Moreno E; Jiménez-Reina L; Moreno-Carazo A; Tinahones FJ; Maraver-Selfa S; Japón MA; García-Arnés JA; Soto-Moreno A; Webb SM; Kineman RD; Culler MD; Castaño JP; Luque RM
    Sci Rep; 2017 Feb; 7():42002. PubMed ID: 28181484
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Critical role of Src and SHP-2 in sst2 somatostatin receptor-mediated activation of SHP-1 and inhibition of cell proliferation.
    Ferjoux G; Lopez F; Esteve JP; Ferrand A; Vivier E; Vely F; Saint-Laurent N; Pradayrol L; Buscail L; Susini C
    Mol Biol Cell; 2003 Sep; 14(9):3911-28. PubMed ID: 12972574
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Distinct agonist-mediated endocytosis of cloned rat somatostatin receptor subtypes expressed in insulinoma cells.
    Roosterman D; Roth A; Kreienkamp HJ; Richter D; Meyerhof W
    J Neuroendocrinol; 1997 Oct; 9(10):741-51. PubMed ID: 9355043
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Overexpression and functional relevance of somatostatin receptor-1, -2, and -5 in endometrium and endometriotic lesions.
    Fasciani A; Quilici P; Biscaldi E; Flamini M; Fioravanti A; Orlandi P; Oliviero J; Repetti F; Bandelloni R; Danesi R; Simoncini T; Bocci G
    J Clin Endocrinol Metab; 2010 Dec; 95(12):5315-9. PubMed ID: 20739383
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Discovery of 4-(3-aminopyrrolidinyl)-3-aryl-5-(benzimidazol-2-yl)-pyridines as potent and selective SST5 agonists for the treatment of congenital hyperinsulinism.
    Zhao J; Wang S; Hee Kim S; Han S; Rico-Bautista E; Sturchler E; Nguyen J; Tan H; Staley C; Karin Kusnetzow A; Betz SF; Johns M; Goulet L; Luo R; Fowler M; Athanacio J; Markison S; Scott Struthers R; Zhu Y
    Bioorg Med Chem Lett; 2022 Sep; 71():128807. PubMed ID: 35605837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.